Management of hand-foot syndrome in patients treated with capecitabine (Xeloda)

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Yvonne Lassere, P Hoff

Abstract

Comparative trials of capecitabine (Xeloda) versus 5-FU/LV in metastatic colorectal cancer have shown that hand-foot syndrome (HFS) was the only clinical adverse event occurring more frequently with capecitabine. Most patients with HFS present with dysesthesia, usually with a tingling sensation in the palms and soles of the hands and feet. This can progress in 3-4 days to burning pain plus well-defined symmetric swelling and erythema. The hands tend to be more commonly affected than the feet, and might even be the only area affected in some patients. HFS can interfere with the general activities of daily living, especially when blistering, moist desquamation, severe pain or ulceration occurs. While HFS is manageable, if ignored it can progress rapidly. However, dose interruption and reduction of capecitabine usually leads to a rapid reversal of signs and symptoms without long-term consequences. Nurses play a key role in educating patients how to recognise HFS, when to interrupt treatment and how to adjust the dose to maintain effective therapy with capecitabine over the long term. It is particularly important that patients and nurses are aware that dose interruption/reduction does not affect the overall antitumour efficacy of c...Continue Reading

References

Jun 1, 1991·Journal of the American Academy of Dermatology·J BrownC Collins
Mar 1, 1991·Journal of the American Academy of Dermatology·B R Baack, W H Burgdorf
Sep 1, 1989·Annals of Plastic Surgery·S S KrollS Dreizen
Oct 15, 1989·Annals of Internal Medicine·S J VukeljaR B Weiss
Dec 1, 1984·Annals of Internal Medicine·J J Lokich, C Moore
Jul 1, 1982·Annals of Internal Medicine·W H BurgdorfR G Ganick
Feb 1, 1995·The Journal of Dermatology·H KomamuraK Yoshikawa
Oct 1, 1994·Cancer Treatment Reviews·J S NgR C Leonard
Sep 1, 1993·Journal of the National Cancer Institute·S J VukeljaD Von Hoff
May 1, 1996·Archives of Dermatology·I HellierJ J Guilhou
Sep 1, 1996·Thérapie·J M Bonnetblanc, P Bernard
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M MiwaH Ishitsuka
Jan 20, 1999·The British Journal of Dermatology·D VakalisA Teknetzis
Aug 10, 1999·Drugs·M Dooley, K L Goa
Aug 14, 1999·Cancer Chemotherapy and Pharmacology·A M LopezD S Alberts
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CassidyUNKNOWN Capecitabine Colorectal Cancer Study Group
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joyce O'ShaughnessyRobert Leonard
Mar 13, 2003·British Journal of Clinical Pharmacology·Ronald GieschkeJean-Louis Steimer
Oct 29, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y H ParkJ-H Chung
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W ScheithauerUNKNOWN X-ACT Study Group
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jim CassidyEduardo Díaz-Rubio
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Cora N SternbergMichelle Holland

❮ Previous
Next ❯

Citations

May 24, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A L BranzanR-M Szeimies
Oct 27, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C SauterH-M Ockenfels
Jun 13, 2009·European Journal of Clinical Pharmacology·Michele D MignognaStefania Leuci
Sep 6, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Snezana SusnjarSinisa Radulovic
Dec 18, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·V FormicaM Roselli
Sep 22, 2007·Investigational New Drugs·Idris Yucel, Gonullu Guzin
Jan 27, 2007·Current Oncology Reports·Smitha PatiyilAminah Jatoi
Jun 22, 2011·Acta Physiologica·E Storkebaum, P Carmeliet
Feb 3, 2012·The Oncologist·Mahmoud S Al-Ahwal
Jan 29, 2010·Expert Opinion on Drug Safety·Laura Bourdeanu, Siu-Fun Wong
Dec 23, 2010·Expert Opinion on Drug Safety·Muhammad Wasif Saif
Mar 8, 2013·Annales de dermatologie et de vénéréologie·V SibaudC Robert
Jul 19, 2011·Clinical Colorectal Cancer·Livia Almeida da CruzRachel Simões Pimenta Riechelmann
May 26, 2009·Actas dermo-sifiliográficas·M Gutiérrez-PascualJ L López-Estebaranz
Sep 16, 2008·Annales de dermatologie et de vénéréologie·D GiaccheroJ-P Lacour
Mar 18, 2008·Journal of the American Academy of Dermatology·Noushin HeidarySusan Burgin
Jan 26, 2008·Seminars in Oncology Nursing·Susan Moore
Mar 14, 2007·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Joan D Webster-GandyKaren Harrold
Mar 18, 2008·British Journal of Clinical Pharmacology·Gérard MilanoPaul Hofman
May 21, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Annette DegenRalf Gutzmer
Oct 5, 2010·Asia-Pacific Journal of Clinical Oncology·Hei Cheul Jeung, Hyun Cheol Chung
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Sara Faithfull, Paula Deery
Mar 31, 2012·Clinical Journal of Oncology Nursing·Nancy Zeller Smith
Oct 21, 2005·Clinical Journal of Oncology Nursing·Pamela Hallquist VialeLaura Zitella
Aug 1, 2013·Clinical Journal of Oncology Nursing·YiYuan ZhaoMing Li
May 10, 2016·Expert Opinion on Pharmacotherapy·J J M Kwakman, C J A Punt
Sep 16, 2016·Chemical Research in Toxicology·Yan LouSu Zeng
Oct 11, 2016·Expert Opinion on Drug Safety·V NikolaouM W Saif
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Wasif SaifMartin R Johnson
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex MolassiotisKaren Luker
Sep 23, 2016·The American Journal of Nursing·Erica Fischer-CartlidgeRosalie Villanueva
Dec 19, 2016·Journal of Cancer Research and Clinical Oncology·Payam AzadehMaryam Farasatinasab
Oct 7, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sarah M GressettFred Hardwicke
Feb 3, 2012·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Debi BhattacharyaSteven Watson
Jan 23, 2018·International Journal of Cancer. Journal International Du Cancer·Xuan-Zhang HuangJian Wu
Apr 28, 2016·Journal of Biomedical Optics·Mao-Dong HuangSora Jung
May 1, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Carol S Viele
Apr 8, 2009·Journal of Burn Care & Research : Official Publication of the American Burn Association·Ioannis GoutosPeter Dziewulski
Jun 30, 2019·Journal of Clinical Pharmacy and Therapeutics·Ali Yaghobi JoybariMajid Mokhtari
Oct 25, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kellen L MeadowsHerbert I Hurwitz
Jul 9, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Diva SilvaIsabel F Almeida
Jun 28, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S JungJ Lademann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Hilde MarséSonia Valverde
Journal of the European Academy of Dermatology and Venereology : JEADV
R Tavares-Bello
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Joan D Webster-GandyKaren Harrold
Annals of Oncology : Official Journal of the European Society for Medical Oncology
J CassidyCapecitabine Colorectal Cancer Study Group
© 2021 Meta ULC. All rights reserved